Skip to main content
Signal8

Rice William G.

SEC insider (Form 3/4/5 filer). CIK 0001761487. Chair, President & CEO at Aptose Biosciences Inc. (APTO). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in TORONTO.

Companies Rice William G. has filed insider reports for

  • Aptose Biosciences Inc. (APTO): Director, Officer, Chair, President & CEO
Rice William G. profile photo

Rice William G.

CIK: 0001761487

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aptose Biosciences Inc. logo
APTO

Aptose Biosciences Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Aptose Biosciences Inc. logo
    APTO

    Aptose Biosciences Inc.

    Jun 30, 2026
    Disposition
    Direct
    613.3K shares at avg. $1.72$1.1M
  • Aptose Biosciences Inc. logo
    APTO

    Aptose Biosciences Inc.

    Nov 25, 2024
    Purchase
    Direct
    100K shares at avg. $0.20$20K

1-2 of 2